HEPATITIS B (HBV) AND C (HCV) REACTIVATION IN INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS TREATED WITH IMMUNOSUPPRESSIVE THERAPY. A NATIONWIDE MULTICENTER STUDY.

(1) Gastroenterology, H Mútua Terrassa, Terrassa

(2) Gastro, H Princesa, Madrid

(3) Gastro, H Clínico, Valencia

(4) Gastro, H Cruces, Bizkaia

(5) Gastro, H Cabueñes, Gijón

(6) Gastro, H Germans Trias i Pujol, Badalona

(7) Gastro, H Río Ortega, Valladolid

(8) Gastro, H del Mar

(9) Gastro, H Clínic, Barcelona

(10) Gastro, H Reina Sofía, Córdoba

(11) Gastro, H Josep Trueta, Girona

(12) Gastro, H Terrassa, Terrassa

(13) Gastro, H Son Dureta, Mallorca

(14) Gastro, H Parc Taulí, Sabadell

(15) Gastro, H General, Alicante

(16) Gastro, H St. Llorenç, Viladecans

(17) Gastro, H Esperit Sant, Barcelona

(18) Gastro, H Mútua Terrassa, Terrassa, Spain



This item was part of the Safety and outcome prediction in IBD session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A34